Study S000106

A Retrospective, Multi-centre, Non-interventional Study Investigating the Clinical Parameters Associated With Saxenda® Use and Discontinuation in Patients in Turkey. INSPIRE Turkey (INvestigate the Impact of Saxenda® on Patient's Weight In a REal World Setting in Turkey) Study

ClinicalTrials.gov record

Registration

Registration: NCT05438186
Acronym: INSPIRE Turkey
Study type: OBSERVATIONAL
Status: WITHDRAWN
Enrollment: 0
Start: 2022-09-01
Primary completion: 2022-09-30
Lead sponsor: Novo Nordisk A/S
Conditions: Obesity
Interventions: DRUG:Liraglutide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1259-8749

Registered primary outcomes

Relative change in body weight [At 52th week after treatment initiation]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.